Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

Chinese researchers say they have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries – an underlying factor in heart disease, which is the leading cause of ...

Using coronary artery calcium (CAC) scoring to guide treatment in intermediate-risk patients, as opposed to usual care, results in a slower development of atherosclerotic plaque, including high-risk ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...

Opens in a new tab or window Equipped with knowledge of their coronary artery calcium (CAC) scan results and a statin prescription, patients were more likely to slow their plaque progression over ...